Amanta Healthcare IPO subscribed 82.60x on Day 3

Amanta Healthcare IPO subscription started on Monday, September 1, 2025, and will close on September 3, 2025, as per the schedule. The price band is set at ₹120 to ₹126 per share with a face value of ₹10.

Amanta Healthcare IPO Subscription Status

Amanta Healthcare IPO subscribed over 82.60x on its last day till 5.00 PM on 3 September 2025.

Amanta Healthcare IPO subscription QIB investors’ portion was 35.86 times, while NII subscribers subscribed 209.40 times, and RII investors subscribed 54.96 times.
The company has received bids for 57,81,83,634 shares against 70,00,000 on offer for the last-day subscription.
Amanta Healthcare IPO subscribed over 82.60x on its day 3.
Amanta Healthcare IPO subscribed over 19.63x on its day 2.
Amanta Healthcare IPO subscribed over 4.62x on its day 1.

About Amanta Healthcare Company

Amanta Healthcare Limited, founded in December 1994, is one of the leading pharmaceutical companies that is involved in the development, manufacturing, and marketing of a wide range of sterile liquid products, mainly parenterals. These are packed in plastic containers using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. IV fluids, diluents, eye drops, and respiratory care solutions are some of the fluid therapy products that the company makes.

Amanta Healthcare also produces irrigation solutions, last-aid items, and eye lubricants under its medical devices segment. The company markets its products through three business divisions: National Sales, International Sales, and Product Partnerships with various Indian and foreign pharmaceutical companies. Under its own brand, the company makes over 45 generic products and sells them in India, through 320 distributors and stockists. The company employs a total of 1,718 employees as of March 31, 2025.

Amanta Healthcare Financial Report

The company reported revenue of ₹276 crores in 2025 against ₹282 crores in 2024. The company reported a profit of ₹10.50 crores in 2025 against a profit of ₹3.63 crores in 2024.

Amanta Healthcare IPO GMP:

Amanta Healthcare IPO GMP was ₹13 as of Wednesday, 3 September. That indicates the IPO is trading at ₹139 with a ₹13 premium in the grey market against the issue price of ₹126.

Vijay Prajapati

An experienced stock market professional with expertise in IPO research, market insights, and equity strategies. With a strong background in research and capital markets, he delivers comprehensive coverage on upcoming IPOs, subscription patterns, grey market premium (GMP), and post-listing performance, along with detailed reviews, recommendations, and technical analysis.

Add IPOWatch to your Google News feed.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.